test

Manish Mital

@Braidwell Lp

Latest period2024 - Q3ReportedManaged Assets$3.528BTotal holdings81
Assets growth rate10.68%Assets growth rate (2-Q avg)6.71%Continuous growth in asset value3 quarters

Portfolio positions

This chart displays the top 10 holdings in Braidwell Lp's 2024 - Q3 portfolio, based on their 13F SEC filing, out of a total of 81 positions.

Assets under management

The assets under management (AUM) of Braidwell Lp over the past 10 years (40 quarters) show continuous growth in total asset value over the last 3 quarters. As of the latest 13F SEC filing for 2024 - Q3, they manage 3.528B in assets, with a quarterly growth rate of 10.68% and a 2-quarter average growth rate of 6.71%. The portfolio is managed by Manish Mital, and others.

Portfolio holdings

CurrentNew PositionIncreasedDecreasedExited
InvestmentPortfolio %Reported Value
0320⤦Amphastar Pharmaceuticals In
Recent Activity
New Position
0.56%
$19.521M
18.4M shares@ $1.07 avg price
EXASExact Sciences Corp
Recent Activity
Decreased -74.93%
0.56%
$19.494M
286,178 shares@ $68.12 avg price
OCULOcular Therapeutix Inc
Recent Activity
Increased 36.26%
0.56%
$19.486M
2.24M shares@ $8.7 avg price
IMTXImmatics N.v
Recent Activity
New Position
0.54%
$18.799M
1.648M shares@ $11.42 avg price
IRWDIronwood Pharmaceuticals Inc
Recent Activity
0.52%
$18.286M
4.438M shares@ $4.13 avg price
BSXBoston Scientific Corp
Recent Activity
New Position
0.45%
$15.855M
189,200 shares@ $83.8 avg price
DNTHDianthus Therapeutics Inc
Recent Activity
Increased 34.58%
0.39%
$13.517M
493,687 shares@ $27.38 avg price
FDMT4d Molecular Therapeutics In
Recent Activity
Increased 231.69%
0.38%
$13.247M
1.225M shares@ $10.82 avg price
CELCCelcuity Inc
Recent Activity
Increased 71.17%
0.38%
$13.185M
884,306 shares@ $14.91 avg price
ORKAOruka Therapeutics Inc
Recent Activity
New Position
0.36%
$12.64M
515,726 shares@ $24.51 avg price